EUVIMEDEUVIMED entdecken
Kommentar

Hot on the trail in the TME: Clues from a trilogy of checkpoint inhibitor trials in nasopharyngeal cancer

Brigette B Y Ma, Quynh Thu Le

Cancer Cell · 2023

DOI: 10.1016/j.ccell.2023.04.013 ↗

Kurz gefasst

Kommentar in der Zeitschrift Cancer Cell, 2023. Verfasst von Brigette B Y Ma und 1 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, The Chines…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: NIDCR, Bristol-Myers Squibb, Merck Sharp and Dohme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsNasopharyngeal NeoplasmsHumansPrognosisB7-H1 AntigenTumor Microenvironment

Substanzen

B7-H1 Antigen

Autor:innen und Institutionen

  • State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Department of Radiation Oncology, Stanford University, Stanford, CA, USA. Electronic address: qle@stanford.edu.

Förderung

  • NIDCR
  • Bristol-Myers Squibb
  • Merck Sharp and Dohme
  • Chinese University of Hong Kong
  • NCI

Zitieren

APA

Ma, B. B. Y., & Thu Le, Q. (2023). Hot on the trail in the TME: Clues from a trilogy of checkpoint inhibitor trials in nasopharyngeal cancer. Cancer Cell. https://doi.org/10.1016/j.ccell.2023.04.013

Vancouver

Ma BBY, Thu Le Q. Hot on the trail in the TME: Clues from a trilogy of checkpoint inhibitor trials in nasopharyngeal cancer. Cancer Cell. 2023. doi:10.1016/j.ccell.2023.04.013

BibTeX
@article{Ma2023,
  author = {Ma, Brigette B Y and Thu Le, Quynh},
  title = {Hot on the trail in the TME: Clues from a trilogy of checkpoint inhibitor trials in nasopharyngeal cancer},
  journal = {Cancer Cell},
  year = {2023},
  doi = {10.1016/j.ccell.2023.04.013}
}
Kostenlos starten →